Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primidone for Clopidogrel Resistance
NCT02008123Phase 2Withdrawn
- Sponsor
- Dent Neurosciences Research Center, Inc.
- Start
- Aug 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of primidone in stroke, Transient Ischemic Attack (TIA), sponsored by Dent Neurosciences Research Center, Inc.. Planned start Aug 2013; status: withdrawn.
02
Drugs
primidone
03
Conditions
strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT02008123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008123.